Skip to main content
Back to King's College London homepage

Dr Fox collaborates internationally within the fields of HIV and SARS-CoV-2 infection.

People

Julie Fox

Professor of HIV and Sexual Health

Sophie Lam

Project Manager

Projects

HIV virus
CHAPS

The Combined HIV Adolescent Prevention Study (CHAPS) is a collaborative African / European HIV prevention study running in South Africa, Uganda and Zimbabwe from 2018 to 2021. The overall aims of the project are to investigate the acceptability and feasibility of implementing daily and on-demand PrEP (pre-exposure prophylaxis) among adolescents in South Africa, Uganda and Zimbabwe and to determine an on-demand PrEP dosing schedule for insertive sex. The study is divided into 3 separate phases; phase 1 is a Social Science study with the aim of identifying barriers to medication adherence, phase 2 is the clinical trial which involves giving men TDF-FTC or TAF-FTC as oral PrEP before Voluntary Male Medical Circumcision and evaluating protection through ex vivo challenge while phase 3 will investigate the efficacy of postexposure administration of the drugs.

covid virus
COVAB: COVID-19 antibody repertoires in infection and vaccination

COVAB is a collaboration between the UK, South African, Sweden and Uganda to explore SARS-CoV-2 infection in terms of antibody development, mechanisms of transmission and ways to engage the public in vaccine delivery. The programme builds on capacity development from the EDCTP-CHAPS HIV prevention programme led by Dr Fox.

COVAB-B logo
COVAB-B

COVAB- B is a collaboration between the UK and Switzerland to explore SARS-CoV-2 antibody repertoires in infection and following vaccination . The programme builds on capacity development from the EDCTP- SARS-CoV-2- COVAB programme led by Dr Fox.

CHERUB logo
CHERUB

CHERUB is one of the first cooperatives of UK Biomedical Research Centres to explore one of the most exciting new fields of biomedical research – HIV Cure. Internationally-recognised researchers from five Biomedical Research Centers are working together to provide a unique experimental medicine approach to new HIV therapeutic strategies. CHERUB will be the UK’s flagship in this field, bringing together, amongst others, clinicians, virologists, immunologists, molecular biologists and mathematical modellers under the umbrella of the National Institute of Health Research.

Mobile Men updated dimensiosn logo 380x215
MOBILE MEN

Assessing implementation effectiveness of LA-CAB and oral FTC-TDF (daily and coitally dependent) on retention in care, coital coverage, and PrEP choice in men who are mobile for work.

Publications

    News

    King's study provides vital information to guide COVID-19 vaccine development

    The researchers examined antibodies from people who had recovered from COVID-19 in multiple countries.

    A community COVID-19 testing site

    People

    Julie Fox

    Professor of HIV and Sexual Health

    Sophie Lam

    Project Manager

    Projects

    HIV virus
    CHAPS

    The Combined HIV Adolescent Prevention Study (CHAPS) is a collaborative African / European HIV prevention study running in South Africa, Uganda and Zimbabwe from 2018 to 2021. The overall aims of the project are to investigate the acceptability and feasibility of implementing daily and on-demand PrEP (pre-exposure prophylaxis) among adolescents in South Africa, Uganda and Zimbabwe and to determine an on-demand PrEP dosing schedule for insertive sex. The study is divided into 3 separate phases; phase 1 is a Social Science study with the aim of identifying barriers to medication adherence, phase 2 is the clinical trial which involves giving men TDF-FTC or TAF-FTC as oral PrEP before Voluntary Male Medical Circumcision and evaluating protection through ex vivo challenge while phase 3 will investigate the efficacy of postexposure administration of the drugs.

    covid virus
    COVAB: COVID-19 antibody repertoires in infection and vaccination

    COVAB is a collaboration between the UK, South African, Sweden and Uganda to explore SARS-CoV-2 infection in terms of antibody development, mechanisms of transmission and ways to engage the public in vaccine delivery. The programme builds on capacity development from the EDCTP-CHAPS HIV prevention programme led by Dr Fox.

    COVAB-B logo
    COVAB-B

    COVAB- B is a collaboration between the UK and Switzerland to explore SARS-CoV-2 antibody repertoires in infection and following vaccination . The programme builds on capacity development from the EDCTP- SARS-CoV-2- COVAB programme led by Dr Fox.

    CHERUB logo
    CHERUB

    CHERUB is one of the first cooperatives of UK Biomedical Research Centres to explore one of the most exciting new fields of biomedical research – HIV Cure. Internationally-recognised researchers from five Biomedical Research Centers are working together to provide a unique experimental medicine approach to new HIV therapeutic strategies. CHERUB will be the UK’s flagship in this field, bringing together, amongst others, clinicians, virologists, immunologists, molecular biologists and mathematical modellers under the umbrella of the National Institute of Health Research.

    Mobile Men updated dimensiosn logo 380x215
    MOBILE MEN

    Assessing implementation effectiveness of LA-CAB and oral FTC-TDF (daily and coitally dependent) on retention in care, coital coverage, and PrEP choice in men who are mobile for work.

    Publications

      News

      King's study provides vital information to guide COVID-19 vaccine development

      The researchers examined antibodies from people who had recovered from COVID-19 in multiple countries.

      A community COVID-19 testing site

      Our Partners

      EDCTP

      EU

      Imperial College of Science Technology and Medicine, United Kingdom

      London School of Hygiene and Tropical Medicine (LSHTM), United Kingdom

      University of Liverpool

      Karolinska Institute, Sweden

      Uganda Virus Research Institute (UVRI), Uganda

      Desmond Tutu HIV Foundation

      University of Zimbabwe College of Health Sciences – Clinical Trials Research Centre

      University of Cape Town

      Perinatal HIV Research Unit (PHRU), South Africa

      Perinatal HIV Research Unit

      WITS Health Consortium

      EU

      European Union

      Imperial College London

      Imperial College of Science, Technology and Medicine

      Desmond Tutu HIV Foundation

      Desmond Tutu Health Foundation

      University of Cape Town

      University of Cape Town

      University of Zimbabwe College of Health Sciences Clinical Trials Research Centre

      University of Zimbabwe College of Health Sciences Clinical Trials Research Centre

      The Perinatal HIV Research Unit

      The Perinatal HIV Research Unit

      Wits Health Consortium

      Wits Health Consortium